Atazanavir Sulfate
Spezifikationen
229975-97-7CAS-Nummer
620-495-2EG-Nummer
methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate;sulfuric acidIUPAC-Name
C38H54N6O11SChemische Formel
802.9 g/molMolekulargewicht
Atazanavir sulfate; 229975-97-7; Atazanavir sulphate; BMS-232632-05; Atazor; Atazanavir so4; Atazanaviri sulfas; 4MT4VIE29P; NSC-742546; 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt); DTXSID401017206; EVOTAZ COMPONENT ATAZANAVIR SULFATE; 232632, BMS; CHEBI:31243; 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt); RefChem:54331; DTXCID801475397; CGP73547; CGP75176; CGP75355; BMS232632; CGP-75176; BMS23263205; BMS 232632 05; 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester; CGP-75136; dimethyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-(4-(2-pyridyl)benzyl)-2,5,6,10,13-pentaazatetradecanedioate sulfate; Reyataz; Atazanavir (sulfate); Atazanavir sulfate [USAN]; MFCD08067748; methyl ((5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamate sulfate; Reyataz (TN); Dimethyl (3S,8S,9S,12S)-9-benzyl-3,12,di-tert-butyl-8-hydroxy-4,11-dioxo-6-(p-2-pyridylbenzyl)-2,5,6,10,13-pentaazatetradecanedioate, sulfate (1:1) (salt); methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate;sulfuric acid; SMR002544693; Atazanavir Bisulfate Salt; BMS-232632 sulfate; UNII-4MT4VIE29P; C38H54N6O11S; 229975-97-7 (sulfate); Atazanavir sulfate RS; Atazanavir sulfate CRS; Atazanavir (as sulfate); MLS003915641; MLS006010199; SCHEMBL341700; orb1225587; orb1310937; ATAZANAVIR SO4 [VANDF]; ATAZANAVIR SULFATE [MI]; Atazanavir sulfate (JAN/USAN); ATAZANAVIR SULFATE [JAN]; CHEMBL1200678; SCHEMBL29362158; Atazanavir (sulfate) (Standard); DQSGVVGOPRWTKI-QVFAWCHISA-N; GLXC-06688; HY-17367AR; ATAZANAVIR SULFATE [MART.]; ATAZANAVIR SULFATE [USP-RS]; ATAZANAVIR SULFATE [WHO-DD]; ATAZANAVIR SULFATE [WHO-IP]; EX-A4010; HY-17367A; Atazanavir Sulfate [USP MONOGRAPH]; AKOS016000176; ATAZANAVIR SULPHATE [EMA EPAR]; CCG-270493; CS-1890; FA29047; NSC 742546; ATAZANAVIR SULFATE [ORANGE BOOK]; ATAZANAVIR SULFATE [EP MONOGRAPH]; 2,5,6,10,13-Pentaazatetradecanedioic acid, 3-12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((-4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt); AS-14954; ATAZANAVIRI SULFAS [WHO-IP LATIN]; DA-61286; A3411; A4040; SW220258-1; D01276; SBI-0654095.0001; Q27114238; 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, 1,14-dimethyl ester, (3S,8S,9S,12S)-, sulfate; 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, 1,14-dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1); methyl ((5S,8S,9S,14S)-8-benzyl-5-(tert-butyl)-9-hydroxy-15,15-dimethyl-3,6,13-trioxo-11-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,11,12-tetraazahexadecan-14-yl)carbamate sulfate; Methyl [(5S,10S,11S,14S)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-[[4-(pyridin-2-yl)phenyl]methyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate sulfate; methyl N-[(1S)-1-[[(1S,2S)-1-benzyl-2-hydroxy-3-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[[4-(2-pyridyl)phenyl]methyl]amino]propyl]carbamoyl]-2,2-dimethyl-propyl]carbamate;sulfuric acid; Methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]am ino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamate sulfate; Sulfuric acid--methyl [(5S,10S,11S,14S)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-{[4-(pyridin-2-yl)phenyl]methyl}-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate (1/1)Synonyme
Produkte, die Atazanavir Sulfate enthalten
ATAZANAVIR TEVA 300 MG CAPSULAS DURAS EFGATAZANAVIR TEVA 200 MG CAPSULAS DURAS EFGATAZANAVIR MYLAN 300 MG CAPSULAS DURAS EFGATAZANAVIR MYLAN 200 MG CAPSULAS DURAS EFGATAZANAVIR KRKA 300 MG CAPSULAS DURAS EFGATAZANAVIR KRKA 200 MG CAPSULAS DURAS EFGATAZANAVIR KRKA 150 MG CAPSULAS DURAS EFGEVOTAZ 300 MG/150 MG COMPRIMIDOS RECUBIERTOS CON PELICULAATAZANAVIR STADA 300 MG CAPSULAS DURAS EFGATAZANAVIR STADA 200 MG CAPSULAS DURAS EFGREYATAZ 300 mg, géluleREYATAZ 200 mg, gélule
Seite 1 von 3
Unternehmen, die Atazanavir Sulfate verkaufen
TP
Teva Pharma S.L.U.SpainSA
SANDOZFranceTS
TEVA SANTEFranceBS
Bristol-Myers Squibb Pharma EeigSpainSeite 1 von 2